Cleared Traditional

EBV-VCA IGG ELISA TEST, MODEL EBG-100

K020706 · Pan Bio Pty. , Ltd. · Microbiology
Jun 2002
Decision
101d
Days
Class 1
Risk

About This 510(k) Submission

K020706 is an FDA 510(k) clearance for the EBV-VCA IGG ELISA TEST, MODEL EBG-100, a Antiserum, Cf, Epstein-barr Virus (Class I — General Controls, product code GNP), submitted by Pan Bio Pty. , Ltd. (Windsor, AU). The FDA issued a Cleared decision on June 13, 2002, 101 days after receiving the submission on March 4, 2002. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3235.

Submission Details

510(k) Number K020706 FDA.gov
FDA Decision Cleared SESE
Date Received March 04, 2002
Decision Date June 13, 2002
Days to Decision 101 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GNP — Antiserum, Cf, Epstein-barr Virus
Device Class Class I — General Controls
CFR Regulation 21 CFR 866.3235

Similar Devices — GNP Antiserum, Cf, Epstein-barr Virus

All 19
EBV-EBNA IGG ELISA KIT, MODEL EBG-100
K020707 · Pan Bio Pty. , Ltd. · Jun 2002
EBV V VCA IGM ELISA KIT MODEL# EBM-200
K020717 · Pan Bio Pty. , Ltd. · Jun 2002
IS EBV-EBNA-1 IGG ELISA TEST SYSTEM
K981829 · Diamedix Corp. · Feb 1999
IS EBV-EA-D IGG ELISA TEST SYSTEM
K981831 · Diamedix Corp. · Feb 1999
EIA FOR IGG ANTIBODY TO EBV VCA IN HUMAN SERUM
K901156 · Granbio, Inc. · Sep 1990
SEROLOGICAL TEST KIT FOR IGG ANTI. EPSTEIN-BARR VI
K883670 · Electro-Nucleonics, Inc. · Apr 1989